These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36311296)

  • 21. Oral or Vaginal Misoprostol for Labor Induction and Cesarean Delivery Risk.
    Handal-Orefice RC; Friedman AM; Chouinard SM; Eke AC; Feinberg B; Politch J; Iverson RE; Yarrington CD
    Obstet Gynecol; 2019 Jul; 134(1):10-16. PubMed ID: 31188317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buccal vs vaginal misoprostol combined with Foley catheter for cervical ripening at term (the BEGIN trial): a randomized controlled trial.
    Gomez HB; Hoffman MK; Caplan R; Ruhstaller K; Young MHH; Sciscione AC
    Am J Obstet Gynecol; 2021 May; 224(5):524.e1-524.e8. PubMed ID: 33617796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Refining the clinical definition of active phase arrest of dilation in nulliparous women to consider degree of cervical dilation as well as duration of arrest.
    Kawakita T; Gold SL; Huang JC; Iqbal SN
    Am J Obstet Gynecol; 2021 Sep; 225(3):294.e1-294.e14. PubMed ID: 33798479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.
    Mustafa HJ; Seif K; Javinani A; Aghajani F; Orlinsky R; Alvarez MV; Ryan A; Crimmins S
    Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100682. PubMed ID: 35728780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal and neonatal outcomes with mechanical cervical dilation plus misoprostol compared to misoprostol alone for cervical ripening; a systematic review of literature and metaanalysis.
    Nasioudis D; Kim SW; Schoen C; Levine LD
    Am J Obstet Gynecol MFM; 2019 May; 1(2):101-111. PubMed ID: 33345815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of labor with an unfavorable cervix: how does BMI affect success? (‡).
    Lassiter JR; Holliday N; Lewis DF; Mulekar M; Abshire J; Brocato B
    J Matern Fetal Neonatal Med; 2016 Sep; 29(18):3000-2. PubMed ID: 26513375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interdelivery weight gain and risk of cesarean delivery following a prior vaginal delivery.
    Dude AM; Lane-Cordova AD; Grobman WA
    Am J Obstet Gynecol; 2017 Sep; 217(3):373.e1-373.e6. PubMed ID: 28526451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaginal assessment and expedited amniotomy in oral misoprostol labor induction in nulliparas: a randomized trial.
    Win ST; Tan PC; Balchin I; Khong SY; Si Lay K; Omar SZ
    Am J Obstet Gynecol; 2019 Apr; 220(4):387.e1-387.e12. PubMed ID: 30633917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized comparison of misoprostol and dinoprostone for preinduction cervical ripening and labor induction.
    Chang CH; Chang FM
    J Formos Med Assoc; 1997 May; 96(5):366-9. PubMed ID: 9170825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of cervical ripening modalities among overweight and obese nulliparous gravidas.
    Sarumi MA; Gherman RB; Bell TD; Jairath P; Johnson MJ; Burgess AL
    J Matern Fetal Neonatal Med; 2020 Nov; 33(22):3804-3808. PubMed ID: 30810422
    [No Abstract]   [Full Text] [Related]  

  • 31. Outcomes of Elective Induction of Labor versus Expectant Management among Obese Women at ≥39 Weeks.
    Palatnik A; Kominiarek MA
    Am J Perinatol; 2020 Jun; 37(7):695-707. PubMed ID: 31039597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for failed induction of labor among pregnant women with Class III obesity.
    Kerbage Y; Senat MV; Drumez E; Subtil D; Vayssiere C; Deruelle P
    Acta Obstet Gynecol Scand; 2020 May; 99(5):637-643. PubMed ID: 31863451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of two management options for labor induction following unsuccessful prostaglandin E2 ripening.
    Gulersen M; DiSturco M; Krantz DA; Bornstein E
    J Matern Fetal Neonatal Med; 2022 May; 35(9):1759-1763. PubMed ID: 32449419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe maternal and neonatal morbidity after attempted operative vaginal delivery.
    Panelli DM; Leonard SA; Joudi N; Girsen AI; Judy AE; El-Sayed YY; Gilbert WM; Lyell DJ
    Am J Obstet Gynecol MFM; 2021 May; 3(3):100339. PubMed ID: 33631384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First stage of labor progression in women with large-for-gestational age infants.
    Blankenship SA; Woolfolk CL; Raghuraman N; Stout MJ; Macones GA; Cahill AG
    Am J Obstet Gynecol; 2019 Dec; 221(6):640.e1-640.e11. PubMed ID: 31238039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregnancy Outcomes after Early Amniotomy among Class III Obese Gravidas Undergoing Induction of Labor.
    Pasko DN; Miller KM; Jauk VC; Subramaniam A
    Am J Perinatol; 2019 Apr; 36(5):449-454. PubMed ID: 30396229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for complete uterine rupture.
    Al-Zirqi I; Daltveit AK; Forsén L; Stray-Pedersen B; Vangen S
    Am J Obstet Gynecol; 2017 Feb; 216(2):165.e1-165.e8. PubMed ID: 27780708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of labor at term with vaginal misoprostol or a prostaglandin E2 pessary: a noninferiority randomized controlled trial.
    Gaudineau A; Senat MV; Ehlinger V; Gallini A; Morin M; Olivier P; Roth E; Orusco E; Javoise S; Fort J; Lavergne C; Arnaud C; Rozenberg P; Vayssiere C;
    Am J Obstet Gynecol; 2021 Nov; 225(5):542.e1-542.e8. PubMed ID: 33887241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of misoprostol vaginal insert compared with oral misoprostol in the induction of labor of nulliparous women: A randomized national multicenter trial.
    Hokkila E; Kruit H; Rahkonen L; Timonen S; Mattila M; Laatio L; Ordén MR; Uotila J; Luukkaala T; Tihtonen K
    Acta Obstet Gynecol Scand; 2019 Aug; 98(8):1032-1039. PubMed ID: 30771243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High- vs low-dose oxytocin in lean and obese women: a double-blinded randomized controlled trial.
    Wei RM; Bounthavong M; Hill MG
    Am J Obstet Gynecol MFM; 2022 Jul; 4(4):100627. PubMed ID: 35358738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.